Logo

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice

1, 2, 3, 4, 5, 6, 7, 8, 9, 10

  1. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Madrid; and Universidad Camilo José Cela, Madrid, Spain. lleon.hcsc@salud.madrid.org
  2. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Madrid, Spain.
  3. Rheumatology Unit, Hospital Clínico San Carlos, Madrid, Spain.
  4. Rheumatology Unit, Hospital Clínico San Carlos, Madrid, Spain.
  5. Rheumatology Unit, Hospital Clínico San Carlos, Madrid, Spain.
  6. Rheumatology Unit, Hospital Clínico San Carlos, Madrid, Spain.
  7. Rheumatology Department and Health Research Institute (IdISsC), Hospital Clínico San Carlos, Madrid, Spain.
  8. Rheumatology Unit, Hospital Clínico San Carlos, Madrid, Spain.
  9. Rheumatology Unit, Hospital Clínico San Carlos, Madrid; and Medicine Department, Universidad Complutense, Madrid, Spain.
  10. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IDISSC), Hospital Clinico San Carlos, Madrid, Spain.

CER11166 Submission on line
2018 Vol.36, N°1 - PI 0173
Erratum Corrige

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

PMID: 29461961 [PubMed]

Received: 06/02/2018 - Accepted : 06/02/2018 - In Press: 06/02/2018 - Published: 06/02/2018